Do you want to read an article? Please log in or register.
Functional aging in fibrotic interstitial lung disease: The impact of frailty on adverse health outcomes
Interstitial Lung Disease
Related content
RECOMMENDED
Body composition, muscle function, and physical performance in fibrotic interstitial lung disease: a prospective cohort study
Respir Res.
Guler SA, Hur SA, Lear SA, Camp PG, Ryerson CJ
doi: 10.1186/s12931-
RECOMMENDED
Interstitial Lung Disease
Predicting outcomes in rheumatoid arthritis related interstitial lung disease
Eur Respir J.
Jacob J, Hirani N, van Moorsel CHM, Rajagopalan S, Murchison JT, van Es HW, Bartholmai BJ, van Beek FT, Struik MHL, Stewart GA, Kokosi M, Egashira R, Brun AL, Cross G, Barnett J, Devaraj A, Margaritopoulos G, Karwoski R, Renzoni E, Maher TM, Wells AU
doi: 10.1183/13993003.00869-2018.
RECOMMENDED
Interstitial Lung DiseasePulmonary Fibrosis
Fibrotic interstitial lung diseases and air pollution: a systematic literature review
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Eur Respir Rev.
Harari S, Raghu G, Caminati A, Cruciani M, Franchini M, Mannucci P
doi: 10.1183/16000617.0093-2020.
RECOMMENDED
COPD
Accelerated epigenetic aging as a risk factor for chronic obstructive pulmonary disease and decreased lung function in two prospective cohort studies
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Aging (Albany NY).
Breen M, Nwanaji-Enwerem JC, Karrasch S, Flexeder C, Schulz H, Waldenberger M, Kunze S, Ollert M, Weidinger S, Colicino E, Gao X, Wang C, Shen J, Just AC, Vokonas P, Sparrow D, Hou L, Schwartz JD, Baccarelli AA, Peters A, Ward-Caviness CK
doi: 10.18632/aging.103784.
Interstitial Lung DiseasePulmonary Fibrosis
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease: An International Multicenter Study
Am J Respir Crit Care Med.
Drake TM, Docherty AB, Harrison EM, Quint JK, Adamali H, Agnew S, Babu S, Barber CM, Barratt S, Bendstrup E, Bianchi S, Castillo Villegas D, Chaudhuri N, Chua F, Coker R, Chang W, Cranshaw A, Crowley LE, Dosanjh D, Fiddler CA, Forrest IA, George PM, Gibbons MA, Groom K, Haney S, Hart SP, Heiden E, Henry M, Ho LP, Hoyles RK, Hutchinson J, Hurley K, Jones MG, Jones S, Kokosi M, Kreuter M, Mackay LS, Mahendran S, Margaritopoulos G, Molina-Molina M, Molyneaux PL, O'Brien A, O'Reilly K, Packham A, Parfrey H, Poletti V, Porter JC, Renzoni E, Rivera-Ortega P, Russell AM, Saini G, Spencer LG, Stella GM, Stone H, Sturney S, Thickett D, Thillai M, Wallis T, Ward K, Wells AU, West A, Wickremasinghe M, Woodhead F, Hearson G, Howard L, Baillie JK, Openshaw PJM, Semple MG, Stewart I, Jenkins RG, ISARIC4C Investigators.
doi: 10.1164/rccm.202007-2794OC.
RECOMMENDED
Interstitial Lung DiseasePulmonary Fibrosis
Prevalence and prognostic impact of physical frailty in interstitial lung disease: A prospective cohort study
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Respirology
Farooqi MAM, O'Hoski S, Goodwin S, Makhdami N, Aziz A, Cox G, Wald J, Ryerson CJ, Beauchamp MK, Hambly N, Kolb M
doi: 10.1111/resp.14066
RECOMMENDED
Pulmonary FibrosisRespiratory Tract InfectionFurther Publications
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial
Lancet Respir Med.
Visca D, Mori L, Tsipouri V, Fleming S, Firouzi A, Bonini M, Pavitt MJ, Alfieri V, Canu S, Bonifazi M, Boccabella C, De Lauretis A, Stock CJW, Saunders P, Montgomery A, Hogben C, Stockford A, Pittet M, Brown J, Chua F, George PM, Molyneaux PL, Margaritopoulos GA, Kokosi M, Kouranos V, Russell AM, Birring SS, Chetta A, Maher TM, Cullinan P, Hopkinson NS, Banya W, Whitty JA, Adamali H, Spencer LG, Farquhar M, Sestini P, Wells AU, Renzoni EA
doi: 10.1016/
RECOMMENDED
Interstitial Lung Disease
Clinical and Functional Characteristics of Patients with Unclassifiable Interstitial Lung Disease (uILD): Long-Term Follow-Up Data from European IPF Registry (eurIPFreg)
★ 2
Recommended by
Dr Martin Frey, Faculty Member
J Clin Med.
Krauss E, El-Guelai M, Pons-Kuehnemann J, Dartsch RC, Tello S, Korfei M, Mahavadi P, Breithecker A, Fink L, Stoehr M, Majeed RW, Seeger W, Crestani B, Guenther A
doi: 10.3390/jcm9082499.
Interstitial Lung DiseasePulmonary Fibrosis
Minimum important difference of the EQ-5D-5L and EQ-VAS in fibrotic interstitial lung disease
Thorax.
Tsai APY, Hur SA, Wong A, Safavi M, Assayag D, Johannson KA, Morisset J, Fell C, Fisher JH, Manganas H, Shapera S, Cox G, Gershon AS, Hambly N, Khalil N, To T, Wilcox PG, Halayko A, Kolb MR, Ryerson CJ
doi: 10.1136/thoraxjnl-2020-214944.